University of South Florida
Tampa, Florida, 33612, United States
NCT Number: NCT02311257
The purpose of this study is to learn about the use of nutritional supplements in patients with mitochondrial disease.
Looking for future studies?
Notify MeAll sexes
Observational
Tampa, Florida, 33612, United States
Our goal is to better assess which nutritional supplements are prescribed to patients with mitochondrial disorders, the monitoring obtained and whether any subjective improvements are noted by the patients or their caregivers.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Up to one year after study activation.
This cross-sectional survey will assess nutritional supplements used by patients with mitochondrial disease.
Time frame: Upt to one year after study activation.
This cross-sectional survey will assess patients' and parents' attitudes (comfort level and perceptions of efficacy) of use of nutritional supplements in patients with mitochondrial disease.
University of South Florida
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02154711
Metabolic Diseases, Mitochondrial Disease
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT00786539
Metabolic Diseases, Mitochondrial Disease
Irvine, California, United States
View Trial DetailsNCT04643249
Metabolic Diseases, Mitochondrial Disease
Leeds, United Kingdom
View Trial DetailsNCT02544217
Brain Diseases, Brain Diseases, Metabolic
Ghent, Belgium
View Trial Details